Andrew Kuykendall, MD, discusses the background, methods, and design of a phase 2 study which evaluated fedratinib.

Hematology oncology is a medical specialty concerned with diagnosing and treating blood, bone marrow, and lymphatic system cancers such as leukemia and lymphoma. It is sometimes also referred to as ...

Lower risk for bleeding without increase in ischemic events seen for patients with acute coronary syndrome. HealthDay News — For patients with acute coronary syndrome (ACS) undergoing drug ...